MedPath

Clinical Outcomes in Chronic Low Pain Back Utilizing Activity Trackers

Not Applicable
Terminated
Conditions
Back Pain
Interventions
Behavioral: Step count monitoring with consulting
Behavioral: Step count monitoring without consultation
Device: Fitbit tracker
Registration Number
NCT03385083
Lead Sponsor
New York Institute of Technology
Brief Summary

This is a randomized controlled study to assess the effects of activity monitors, with telehealth follow ups, on the treatment of chronic low back pain subjects.

Detailed Description

This is a randomized controlled study to assess the effects of activity monitors, with telehealth follow ups, on the treatment of chronic low back pain subjects. Subjects with low back pain will present for evaluation to the NYIT Academic Health Care Center. Once serious complications have been ruled out and a diagnosis of chronic low back pain has been made, subjects will be informed about this proposed study and asked if they would like to participate. Voluntary subjects will then be consented by designated investigators. The subjects will then be randomized into either the activity tracker and telemedicine follow up group or the control group.

Once enrolled, all subjects will complete the study as outlined in the procedures. It will involve the use of several validated assessment tools. Following the initial visit, subjects in both groups will return in 6 weeks for reassessment. Subjects in the experimental group will additionally be given an activity tracker and have 2 telemedicine visits at 2 and 4 weeks.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
2
Inclusion Criteria
  • Subject is at least 18 years age and younger than 75 years of age
  • Subjects evaluated and found to have low back lasting longer than 3 months
Exclusion Criteria

The subject suffers from any of the following:

  • Foot drop

  • Recent diagnosis of malignancy

  • Recent infection

  • Saddle anesthesia

  • Urinary or bowel incontinence

  • Progressive neuromotor or sensory loss

    • The subject is unable to complete the assessment tools
    • The subject is pregnant

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ACTIVITY TRACKERStep count monitoring with consultingSubjects in Cohort A will receive standard of care treatments in addition to a Fitbit Flex 2 activity tracker for six weeks and recommendation for daily step counts at initial visit. Cohort A will then meet with researchers via telehealth at 2 weeks and 4 weeks with researchers to review step counts and reaffirm targets. Subjects in Cohorts A will be reassessed in person at the conclusion of the six week period.
ControlFitbit trackerSubjects in Cohort B will receive standard of care treatments in addition to a Fitbit Flex 2 activity tracker for six weeks and recommendation for daily step counts at initial visit. Subjects in Cohorts B will be reassessed in person at the conclusion of the six week period.
ACTIVITY TRACKERFitbit trackerSubjects in Cohort A will receive standard of care treatments in addition to a Fitbit Flex 2 activity tracker for six weeks and recommendation for daily step counts at initial visit. Cohort A will then meet with researchers via telehealth at 2 weeks and 4 weeks with researchers to review step counts and reaffirm targets. Subjects in Cohorts A will be reassessed in person at the conclusion of the six week period.
ControlStep count monitoring without consultationSubjects in Cohort B will receive standard of care treatments in addition to a Fitbit Flex 2 activity tracker for six weeks and recommendation for daily step counts at initial visit. Subjects in Cohorts B will be reassessed in person at the conclusion of the six week period.
Primary Outcome Measures
NameTimeMethod
Oswestry Low Back Pain Disability Questionnaire6 weeks

Back pain assessment tool

Secondary Outcome Measures
NameTimeMethod
Step counts6 weeks

Number of steps per day

Trial Locations

Locations (1)

NYIT

🇺🇸

Old Westbury, New York, United States

© Copyright 2025. All Rights Reserved by MedPath